Strategic Wealth Investment Group LLC trimmed its holdings in STERIS plc (NYSE:STE – Free Report) by 5.0% in the fourth quarter, Holdings Channel reports. The institutional investor owned 4,432 shares of the medical equipment provider’s stock after selling 235 shares during the period. Strategic Wealth Investment Group LLC’s holdings in STERIS were worth $911,000 at the end of the most recent reporting period.
Several other institutional investors have also made changes to their positions in STE. Ashton Thomas Securities LLC bought a new stake in shares of STERIS during the 3rd quarter valued at $25,000. Central Pacific Bank Trust Division bought a new stake in STERIS during the third quarter worth about $28,000. Quarry LP acquired a new stake in STERIS during the third quarter worth about $67,000. Asset Dedication LLC increased its holdings in STERIS by 54.8% in the 3rd quarter. Asset Dedication LLC now owns 291 shares of the medical equipment provider’s stock valued at $71,000 after buying an additional 103 shares during the period. Finally, R Squared Ltd acquired a new position in shares of STERIS in the 4th quarter valued at approximately $78,000. 94.69% of the stock is currently owned by institutional investors.
Insider Activity
In related news, SVP Cary L. Majors sold 1,682 shares of the business’s stock in a transaction on Monday, November 25th. The shares were sold at an average price of $217.32, for a total transaction of $365,532.24. Following the transaction, the senior vice president now owns 11,372 shares in the company, valued at $2,471,363.04. The trade was a 12.88 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.14% of the stock is owned by company insiders.
Analyst Ratings Changes
STERIS Trading Up 0.6 %
Shares of STE stock opened at $221.66 on Friday. STERIS plc has a 1-year low of $197.82 and a 1-year high of $248.24. The company has a current ratio of 2.41, a quick ratio of 1.55 and a debt-to-equity ratio of 0.33. The stock has a market cap of $21.88 billion, a price-to-earnings ratio of 50.61 and a beta of 0.84. The stock has a 50-day moving average of $211.90 and a 200-day moving average of $224.77.
STERIS (NYSE:STE – Get Free Report) last issued its quarterly earnings results on Wednesday, November 6th. The medical equipment provider reported $2.14 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.12 by $0.02. STERIS had a net margin of 8.02% and a return on equity of 13.78%. The firm had revenue of $1.33 billion for the quarter, compared to the consensus estimate of $1.33 billion. During the same quarter in the previous year, the company earned $2.03 EPS. The company’s revenue for the quarter was up 7.3% on a year-over-year basis. On average, equities research analysts forecast that STERIS plc will post 9.11 earnings per share for the current year.
STERIS Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, March 21st. Shareholders of record on Thursday, February 20th will be issued a dividend of $0.57 per share. The ex-dividend date is Thursday, February 20th. This represents a $2.28 dividend on an annualized basis and a yield of 1.03%. STERIS’s payout ratio is currently 52.05%.
About STERIS
STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.
Featured Articles
- Five stocks we like better than STERIS
- 3 Stocks to Consider Buying in October
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- Dividend Capture Strategy: What You Need to Know
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- Quiet Period Expirations Explained
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STE – Free Report).
Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.